دورية أكاديمية
أعرض في EDS

Current trends in the medical treatment of neuropathic low back pain: a Swedish registry-based study of 1.7 million people.

التفاصيل البيبلوغرافية
العنوان: Current trends in the medical treatment of neuropathic low back pain: a Swedish registry-based study of 1.7 million people.
المؤلفون: Nyqvist L; Spine Unit, Department of Orthopedics, Umeå University Hospital, Umeå, Sweden., Åkerstedt J; Spine Unit, Department of Orthopedics, Umeå University Hospital, Umeå, Sweden.; Department of Diagnostics and Intervention, Orthopedics and Spine Surgery, Umeå University, Umeå, Sweden., Thoreson O; Department of Orthopedics, Institute of Clinical Sciences at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. olof.thoreson@gu.se.; Research and Development Primary Health Care Center, Gothenburg, Sweden. olof.thoreson@gu.se.
المصدر: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Jun 20; Vol. 25 (1), pp. 486. Date of Electronic Publication: 2024 Jun 20.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474 (Electronic) Linking ISSN: 14712474 NLM ISO Abbreviation: BMC Musculoskelet Disord Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2000-
مواضيع طبية MeSH: Registries* , Low Back Pain*/epidemiology , Low Back Pain*/therapy , Low Back Pain*/drug therapy , Low Back Pain*/diagnosis , Neuralgia*/epidemiology , Neuralgia*/drug therapy , Neuralgia*/diagnosis , Neuralgia*/therapy , Analgesics, Opioid*/therapeutic use, Humans ; Sweden/epidemiology ; Male ; Female ; Middle Aged ; Adult ; Aged ; Analgesics/therapeutic use ; Prevalence ; Young Adult ; Adolescent ; Aged, 80 and over ; Practice Patterns, Physicians'/trends ; Practice Patterns, Physicians'/statistics & numerical data
مستخلص: Background: Low back pain, a common problem worldwide, causes more global disability than any other condition and is associated with high costs to society. This observational registry-based study describes the current trends in the medical treatment of neuropathic low back pain in the Swedish region of Västra Götaland, which has a population of 1.7 million. The study aims to; (1) identify the prevalence of neuropathic low back pain within the study population; (2) to explore the patterns of medical treatment utilization, including the prevalence and distribution of opioids (OG) and analgesics specified for neuropathic low back pain (NG) and (3) to evaluate the long-term trends and changes in medical treatment practice for neuropathic low back pain over the study period.
Methods: This study includes a descriptive analysis of aggregated data extracted from the Swedish primary care registry VEGA and the pharmaceutical prescription registry Digitalis between the years 2017 and 2021. The data were stratified by year, age, gender, pharmaceutical code (ATC), and sub-diagnoses and presented as the prevalence of unique patients retrieving prescribed medication within six months before or after a registered diagnosis of neuropathic low back pain. The pharmaceutical codes were furthermore grouped into two groups depending on their mechanism of action; opioid group (OG) and neuropathic group (NG).
Results: In all four diagnosis groups, more patients used opioid analgesics than neuropathic analgesics. The greatest difference between the opioid group and neuropathic group was in the lumbar spinal stenosis diagnosis group (67.1% vs. 40.6%), followed by the lumbar root canal stenosis diagnosis (65.9% vs. 44.2%), the nerve root and plexus compressions in intervertebral disc disorders diagnosis (57.5% vs. 40.8%), and lumbago with sciatica diagnosis (38.4% vs. 22.7%).
Conclusions: The trends suggest a general increase in the prescription rate and therefore patients' use of neuropathic analgesics for neuropathic pain associated with the studied diagnoses. However, opioid treatment remains the most common. The results indicate that the treatment for neuropathic low back pain needs to be improved.
(© 2024. The Author(s).)
References: BMJ. 2006 Jun 17;332(7555):1430-4. (PMID: 16777886)
Pharmaceuticals (Basel). 2021 Oct 27;14(11):. (PMID: 34832873)
Annu Rev Neurosci. 2009;32:1-32. (PMID: 19400724)
BMC Musculoskelet Disord. 2010 Sep 10;11:202. (PMID: 20831785)
Eur Spine J. 2018 Nov;27(11):2875-2881. (PMID: 30155730)
J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:21-4. (PMID: 16595438)
Eur J Pain. 2009 Mar;13(3):280-6. (PMID: 18524652)
Prim Health Care Res Dev. 2020 Nov 20;21:e53. (PMID: 33213563)
Spine J. 2008 Jan-Feb;8(1):8-20. (PMID: 18164449)
Spine (Phila Pa 1976). 2000 Apr 15;25(8):980-8. (PMID: 10767812)
BMC Public Health. 2011 Jun 09;11:450. (PMID: 21658213)
Prim Health Care Res Dev. 2021 Aug 11;22:e37. (PMID: 34376265)
Best Pract Res Clin Rheumatol. 2002 Jan;16(1):23-30. (PMID: 11987929)
Eur J Pain. 2010 Aug;14(7):747.e1-7. (PMID: 20036168)
فهرسة مساهمة: Keywords: Neuropathic analgesics; Neuropathic low back pain; Opioids; Pain therapy; Radicular pain
المشرفين على المادة: 0 (Analgesics, Opioid)
0 (Analgesics)
تواريخ الأحداث: Date Created: 20240620 Date Completed: 20240621 Latest Revision: 20240925
رمز التحديث: 20240925
مُعرف محوري في PubMed: PMC11191223
DOI: 10.1186/s12891-024-07599-4
PMID: 38902709
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2474
DOI:10.1186/s12891-024-07599-4